The serotonin-6 receptor as a novel therapeutic target.

Experimental Neurobiology
Hyung-Mun Yun, Hyewhon Rhim

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) is an important neurotransmitter that is found in both the central and peripheral nervous systems. 5-HT mediates its diverse physiological responses through 7 different 5-HT receptor families: 5-HT(1), 5-HT(2), 5-HT(3), 5-HT(4), 5-HT(5), 5-HT(6), and 5-HT(7) receptors. Among them, the 5-HT(6) receptor (5-HT(6)R) is the most recently cloned serotonin receptor and plays important roles in the central nervous system (CNS) and in the etiology of neurological diseases. Compared to other 5-HT receptors, the 5-HT(6)R has been considered as an attractive CNS therapeutic target because it is expressed exclusively in the CNS and has no known isoforms. This review evaluates in detail the role of the 5-HT(6)R in the physiology and pathophysiology of the CNS and the potential usefulness of 5-HT(6)R ligands in the development of therapeutic strategies for the treatment of CNS disorders. Preclinical studies provide support for the use of 5-HT(6)R ligands as promising medications to treat the cognitive dysfunction associated with Alzheimer's disease, obesity, depression, and anxiety.

References

Mar 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J MacDermotM Nirenberg
May 28, 1993·Biochemical and Biophysical Research Communications·M RuatJ C Schwartz
May 30, 1998·Naunyn-Schmiedeberg's Archives of Pharmacology·B GrimaldiG Fillion
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Oct 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L A DawsonP Li
Mar 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Per SvenningssonPaul Greengard
Apr 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sudabeh Shirazi-SouthallGeorge G Nomikos
Jan 4, 2003·Science·Diego J WaltherMichael Bader
Jul 16, 2003·European Journal of Pharmacology·Jean Y ZhangJohn Dunlop
Feb 18, 2004·Current Drug Targets. CNS and Neurological Disorders·D L Nelson
Feb 18, 2004·Current Drug Targets. CNS and Neurological Disorders·Marie L WoolleyKevin C F Fone
Jul 6, 2004·Neurochemistry International·Kayoko OonoMasaya Tohyama
May 17, 2005·Current Pharmaceutical Design·A A Russo-Neustadt, M J Chen
Jul 12, 2005·Pharmacology & Therapeutics·Ellen S Mitchell, John F Neumaier
Aug 2, 2005·Bioorganic & Medicinal Chemistry Letters·Cecilia MattssonHenning Böttcher
Aug 24, 2005·The Journal of Biological Chemistry·Kiran BhaskarGloria Lee
Jan 13, 2006·British Journal of Pharmacology·A Richard Green
Jun 20, 2006·British Journal of Pharmacology·Angels FisasPetrus Johan Pauwels
Dec 26, 2006·The Journal of Biological Chemistry·Hyung-Mun YunHyewhon Rhim
Apr 13, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Per SvenningssonPaul Greengard
Jul 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lee E SchechterChad E Beyer
Feb 1, 2008·European Journal of Pharmacology·Anna Wesołowska, Agnieszka Nikiforuk
May 14, 2008·Combinatorial Chemistry & High Throughput Screening·Hyun-Ji KimHyewhon Rhim
May 15, 2008·Chemical Reviews·David E Nichols, Charles D Nichols
Jun 24, 2008·Behavioural Brain Research·Jason Hannon, Daniel Hoyer
Jul 8, 2008·Neuropharmacology·Joël BockaertAline Dumuis
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Neil UptonDavid J Virley
May 19, 2009·Bioorganic & Medicinal Chemistry·Byung-Hwan LeeHyunah Choo
Jul 28, 2009·Annual Review of Medicine·Miles BergerBryan L Roth

❮ Previous
Next ❯

Citations

Aug 12, 2014·European Journal of Medicinal Chemistry·Felicia Phei Lin Lim, Anton V Dolzhenko
May 30, 2015·Expert Opinion on Investigational Drugs·Daniela Galimberti, Elio Scarpini
Apr 14, 2016·European Journal of Pharmacology·Hue Yu WangSu Jane Wang
Aug 19, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gonzalo VeraGonzalo Recabarren-Gajardo
Sep 30, 2016·Expert Opinion on Emerging Drugs·Francesco PanzaGiancarlo Logroscino
Jan 22, 2019·Expert Opinion on Therapeutic Targets·Nina K Popova, Vladimir S Naumenko
Apr 25, 2020·EMBO Molecular Medicine·Coralie BerthouxCarine Bécamel
Mar 14, 2014·Reviews in the Neurosciences·Anne QuiedevilleThomas Freret
Nov 22, 2013·Reviews in the Neurosciences·Alfredo Meneses
Sep 30, 2017·International Journal of Food Sciences and Nutrition·Amanda Alves Marcelino da SilvaSandra Lopes de Souza
Mar 12, 2019·Experimental Neurobiology·Soon-Hee KimHyewhon Rhim
Dec 11, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Annamaria LubelskaJadwiga Handzlik
Jul 29, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Agnieszka Zagórska, Anna Jaromin
May 31, 2018·Molecular Medicine Reports·Mubashir HassanAhmed A Moustafa
Aug 9, 2020·Frontiers in Neuroscience·Georg A Petroianu, Dietrich E Lorke
Nov 6, 2020·Neuropsychiatric Disease and Treatment·Etsay Weldekidan TsegayZenawi Hagos Gufue
Apr 8, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Rajiv RadhakrishnanDavid Matuskey

❮ Previous
Next ❯

Methods Mentioned

BETA
two-hybrid

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.